Literature DB >> 9973454

Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens.

S Wirtz1, S Finotto, S Kanzler, A W Lohse, M Blessing, H A Lehr, P R Galle, M F Neurath.   

Abstract

We generated transgenic mice for STAT-4, a regulatory protein specifically associated with IL-12 signaling, under the control of a CMV promoter. These mice expressed strikingly increased nuclear STAT-4 levels in lamina propria CD4+ T lymphocytes upon systemic administration of dinitrophenyl-keyhole limpet hemocyanin and developed chronic transmural colitis characterized by infiltrates of mainly CD4+ T lymphocytes. The latter cells produced predominantly TNF and IFN-gamma but not IL-4 upon activation with alphaCD3/CD28 or autologous bacterial Ags, consistent with a Th1-type cell response. Furthermore, chronic colitis in STAT-4 transgenic mice could be adoptively transferred to SCID mice by colonic and splenic CD4+ T cells that were activated with Ags from autologous bacterial flora. These data establish a critical molecular signaling pathway involving STAT-4 for the pathogenesis of chronic intestinal inflammation, and targeting of this pathway may be relevant for the treatment of colitis in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9973454

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

Review 1.  The SAMP1/Yit mouse: another step closer to modeling human inflammatory bowel disease.

Authors:  W Strober; K Nakamura; A Kitani
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 3.  Tumour necrosis factor in mouse models of chronic intestinal inflammation.

Authors:  Christoph Mueller
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

Review 4.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

Review 5.  Mucosal T lymphocytes--peacekeepers and warriors.

Authors:  Hilde Cheroutre; Mitchell Kronenberg
Journal:  Springer Semin Immunopathol       Date:  2005-06-02

Review 6.  Layers of mutualism with commensal bacteria protect us from intestinal inflammation.

Authors:  C Mueller; A J Macpherson
Journal:  Gut       Date:  2006-02       Impact factor: 23.059

Review 7.  Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication.

Authors:  Ilaria Peluso; Francesco Pallone; Giovanni Monteleone
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

8.  Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid.

Authors:  Mansour Mohamadzadeh; Erika A Pfeiler; Jeffrey B Brown; Mojgan Zadeh; Matthew Gramarossa; Elizabeth Managlia; Praveen Bere; Bara Sarraj; Mohammad W Khan; Krishna Chaitanya Pakanati; M Javeed Ansari; Sarah O'Flaherty; Terrence Barrett; Todd R Klaenhammer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

9.  High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis.

Authors:  X Ma; M Torbenson; A R A Hamad; M J Soloski; Z Li
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

Review 10.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.